Related Experiment Video
Updated: May 2, 2026
07:16
Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
13.9K
Regulators of prostate cancer stem cells
1aDepartment of Biochemistry and Molecular Biology bDepartment of Medicine and Greenebaum Cancer Center, University of Maryland School of Medicine c Department of Obstetrics and Gynecology, Johns Hopkins University dBaltimore VA Medical Center, Baltimore, Maryland, USA.
Current Opinion in Oncology
|March 22, 2014
Summary
Prostate cancer stem cells (CSCs) are key to understanding cancer recurrence and metastasis. Research highlights master regulators like OCT4 and SOX2, offering new targets for advanced prostate cancer treatments.
Area of Science:
- Oncology
- Stem Cell Biology
- Molecular Biology
Background:
- Prostate cancer stem cells (CSCs) are increasingly recognized as critical drivers of tumor growth, metastasis, and therapeutic resistance.
- Identifying and characterizing CSCs is essential for developing effective treatments for advanced prostate cancer.
Purpose of the Study:
- To review recent advances in defining the prostate CSC population.
- To highlight key mechanisms regulating CSC survival and metastasis.
Main Methods:
- Review of current literature on prostate cancer stem cell identification.
- Analysis of genetic and epigenetic factors involved in CSC regulation.
- Examination of pluripotent markers and their role in aggressive prostate tumors.
Main Results:
- Master regulators of stemness, including OCT4, SOX2, Bmi-1, and enhancer of zeste homolog 2, are identified in prostate CSCs.
- Elevated levels of these markers correlate with poor prognosis and highly metastatic tumors.
- Prostate CSCs derived from patient tumors offer a model to study survival and proliferation mechanisms.
Conclusions:
- Understanding prostate CSCs is crucial for deciphering the mechanisms of invasive and therapy-resistant prostate cancer.
- Emerging regulatory factors in CSCs present potential therapeutic targets for advanced prostate cancer treatment.
- Targeted drug development based on CSC mechanisms may improve outcomes for patients with recurrent or metastatic disease.
Related Concept Videos
01:23Negative Regulator Molecules
32.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
01:01Regulation of Hematopoietic Stem Cells
3.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
02:40Cancer Stem Cells and Tumor Maintenance
4.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
02:40Cancer Stem Cells and Tumor Maintenance
2.0K
2.0K
01:24Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
02:39Positive Regulator Molecules
5.3K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.3K